Peptide Initiative

Peptides · Peptide comparison

Palmitoyl Oligopeptide vs Snap-8

Elastin-derived signal peptide that stimulates dermal matrix renewal and skin elasticity through matrikine signaling.

An advanced 8-amino-acid peptide that relaxes facial muscles from the outside in—think of it as 'Botox in a bottle' that you apply to your skin to smooth expression lines without needles or injections.

  • Cosmetic
  • Cosmetic

At a glance

Quick comparison

Dose rangePalmitoyl Oligopeptide0.002–0.002 %Snap-810–10 %
FrequencyPalmitoyl OligopeptideOnce dailySnap-8Once daily
AdministrationPalmitoyl OligopeptideTopicalSnap-8Topical application
Cycle lengthPalmitoyl OligopeptideOngoing/indefiniteSnap-8Ongoing/indefinite
Onset speedPalmitoyl OligopeptideModerate (1-2 weeks)Snap-8Moderate (1-2 weeks)
Evidence levelPalmitoyl OligopeptideLimited human trialsSnap-8Moderate human trials (Phase 1-2)

Efficacy

Benefit ratings

Collagen Stimulation

Palmitoyl Oligopeptide82%
Snap-8No recorded rating

Skin Elasticity

Palmitoyl Oligopeptide80%
Snap-8No recorded rating

Skin Hydration

Palmitoyl Oligopeptide78%
Snap-8No recorded rating

Wrinkle Reduction

Palmitoyl OligopeptideNo recorded rating
Snap-888%

Muscle Relaxation

Palmitoyl OligopeptideNo recorded rating
Snap-885%

Skin Smoothing

Palmitoyl OligopeptideNo recorded rating
Snap-882%

Technical data

Compound specifications

Palmitoyl Oligopeptide

Molecular formula
C36H63N5O7 (hexapeptide-12 variant)
Molecular weight
694.9 Da (approximate for palmitoylated hexapeptide)
Half-life
Topical application; degradation rate dependent on formulation pH and temperature
Bioavailability
Enhanced dermal penetration via palmitate conjugation; self-assembles with endogenous skin proteins
CAS number
171263-26-6

Snap-8

Molecular formula
C41H70N16O16S
Molecular weight
1075.16 g/mol
Half-life
Topical activity persists 12-24 hours on skin
Bioavailability
Penetrates stratum corneum; reaches viable epidermis with appropriate formulation
CAS number
868844-74-0

Protocols

Dosing compared

Palmitoyl Oligopeptide

Topical

  • Under 10 ppm (<0.001%) in finished productOnce or twice daily · OngoingIn cosmetics the INCI name Palmitoyl Oligopeptide most often refers to Pal-GHK as used in the Matrixyl 3000 blend; customary leave-on use is below 10 ppm of active peptide [6].
  • Up to ~0.002% in finished productSeveral times daily · OngoingUpper end of reported leave-on concentrations, applied as often as several times daily in surveyed products [6]. Active peptide content remains in the ppm range even at this level.

Snap-8

Topical

  • 3-5% of supplied peptide solution in formulationOnce to twice daily · 4 weeks initial trialSource class: manufacturer recommendation, not peer-reviewed clinical data. Lipotec/Lubrizol recommends 3-10% of supplied peptide solution in formulations [1][2]. No peer-reviewed study has tested any specific concentration of Snap-8 alone in a topical formulation.
  • 10% of supplied peptide solution in formulationTwice daily · Ongoing useSource class: manufacturer recommendation, not peer-reviewed clinical data. Lipotec/Lubrizol recommends up to 10% concentration [1][2]. The wrinkle-reduction percentages attributed to this concentration (such as 63%) originate from manufacturer datasheets, not peer-reviewed publications, and have not been independently verified.

Applications

Best suited for

Palmitoyl Oligopeptide

Individuals seeking collagen and elastin stimulation through topical peptides
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on individuals seeking collagen and elastin stimulation through topical peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with age-related loss of skin firmness and elasticity
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on those with age-related loss of skin firmness and elasticity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for gentle anti-aging actives suitable for sensitive skin
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on people looking for gentle anti-aging actives suitable for sensitive skin. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users wanting to complement retinoid or vitamin C regimens with peptide support
Palmitoyl Oligopeptide is particularly well-suited for individuals focused on users wanting to complement retinoid or vitamin c regimens with peptide support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Snap-8

Expression Line Fighters
If you've noticed those lines that form when you smile, frown, or squint are starting to stick around even when your face is relaxed, Snap-8 is designed exactly for this. It works on the muscle-skin connection that creates these dynamic wrinkles.
Botox-Curious but Needle-Shy
Love the idea of smoother skin but not ready for injections? Snap-8 offers a topical alternative that works through a similar mechanism as Botox—just gentler and without the commitment. Perfect for testing the waters of muscle-relaxing anti-aging.
Prevention-Focused Millennials
Starting in your late 20s or early 30s with preventive skincare? Snap-8 can help keep expression lines from becoming permanent fixtures by calming the repetitive muscle movements that eventually etch wrinkles into your skin.
Sensitive Skin Types
Unlike some anti-aging actives that can be harsh, Snap-8 is remarkably well-tolerated. If retinoids make your skin angry or acids cause irritation, peptides like Snap-8 offer effective anti-aging without the drama.

Safety profile

Side effects

Palmitoyl Oligopeptide

Common

  • Transient Dryness
  • Mild Tingling
  • Product Interaction Sensitivity
  • Minimal Erythema

Uncommon

  • Contact Dermatitis

Serious

  • Allergic Reaction
  • Comedogenic Potential from Palmitic Acid

Snap-8

Common

  • Mild tingling sensation
  • Temporary redness
  • Skin dryness

Uncommon

  • Contact irritation
  • Skin tightness

Serious

  • Allergic reaction

Research status

Safety & evidence

Palmitoyl Oligopeptide

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl oligopeptide has GRAS-equivalent status for cosmetic use with no serious adverse events in safety testing up to 5% w/w in topical formulations. Mild skin irritation reported in <3% of subjects at high concentrations (irritation index 0-1 on 0-10 scale). No dermal penetration beyond stratum corneum in Franz diffusion cell studies. Long-term use data spans 15+ years of cosmetic industry application with no systemic toxicity.

Contraindications

  • Known allergy or hypersensitivity to palmitoylated peptides or formulation excipients
  • Active skin infections or open wounds at the application site
  • Concurrent use with strong oxidizing agents that may degrade peptide structure
  • Severe dermatitis or eczema flares at intended application areas

Snap-8

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not FDA approved
Safety overview
No peer-reviewed study has tested Snap-8 (acetyl octapeptide-3) alone for safety or efficacy. The compound has been included in two published multi-component microneedle patch studies, both of which combined it with several other active ingredients. Avcil et al. (2020) tested a hyaluronic acid microneedle patch loaded with acetyl octapeptide-3 plus palmitoyl tripeptide-5, adenosine, and seaweed extracts in a 12-week monocentric trial on the eye area. None of the subjects reported any primary or cumulative skin reactions [1]. Shin et al. (2024) tested a dissolving microneedle patch containing acetyl octapeptide-3, L-ascorbic acid 2-glucoside, and sodium cyclic lysophosphatidic acid in 24 subjects over 28 days (patch vs placebo on opposite eyes). No adverse effects were reported [2]. In both studies, multiple active ingredients were present — adverse effects cannot be attributed to or excluded from Snap-8 specifically. An FDA in vitro study of the related compound acetyl hexapeptide-8 (Argireline, 6 amino acids vs Snap-8's 8) found that the peptide remains mostly in the stratum corneum (0.22% of applied dose in human skin) with none reaching the dermis, supporting low systemic exposure for topical SNARE-interfering peptides [4].

Contraindications

  • Known allergy to peptide ingredients
  • Active skin infections at application site
  • Open wounds or severe skin irritation
  • Pregnancy (as a precaution due to limited data)

Decision guide

Which is right for you?

Palmitoyl Oligopeptide

Choose Palmitoyl Oligopeptide if…

  • Individuals seeking collagen and elastin stimulation through topical peptides
  • Those with age-related loss of skin firmness and elasticity
  • People looking for gentle anti-aging actives suitable for sensitive skin
  • Users wanting to complement retinoid or vitamin C regimens with peptide support

Snap-8

Choose Snap-8 if…

  • Wrinkle reduction
  • Expression line smoothing
  • Preventive anti-aging
  • Non-invasive cosmetic enhancement